P160-0032 Screening compound: 2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate

P160-0032 Screening compound: 2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate
P160-0032 Screening compound: 2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound P160-0032
2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P160-0032

Molecular Formula

C20H21N3O7S (C20 H21 N3 O7 S)

Compound Name

2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1H,2H,3H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate

IUPAC name

2-[4-methyl-8-(morpholine-4-sulfonyl)-13-dioxo-1H2H3H-pyrrolo[34-c]quinolin-2-yl]ethyl acetate

SMILES

CC(OCCN(C(c1c(C)nc(ccc(S(N2CCOCC2)(=O)=O)c2)c2c11)=O)C1=O)=O

InChI

InChI=1S/C20H21N3O7S/c1-12-17-18(20(26)23(19(17)25)7-10-30-13(2)24)15-11-14(3-4-16(15)21-12)31(27,28)22-5-8-29-9-6-22/h3-4,11H,5-10H2,1-2H3

InChI Key

MWXJJTMEUGWKKY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09971108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.47

Hydrogen Bond Acceptors Count

14.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.511

Distribution Coefficient, logD

0.511

Water Solubility, LogSw

-2.32

Polar Surface Area

99.418

Acid Dissociation Constant (pKa)

24.24

Base Dissociation Constant (pKb)

-2.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

P160-0032 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

GPCR Targeted Library (31838 compounds)

Human Proteases Annotated Library (2868 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

New Agro Library (44492 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands
Agro:
  • Agro

References: we are preparing a list of scientific research reports with P160-0032 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P160-0032?
Check Price and Availability of P160-0032, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P160-0032 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P160-0032
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P160-0032
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P160-0032 available by request